Clinical Trials

Clinical Trials

At Sullivan Dermatology, we strive to provide patients with the most innovative medical care available for their skin conditions. Our research team partners with the world’s top pharmaceutical companies to conduct research and trials that help lead to new, more effective and groundbreaking dermatologic treatments. Putting our patients’ safety first and implementing sound clinical practices is our top priority.

Dr. Tory Sullivan, a Board Certified Dermatologist with over 10 years of experience in conducting clinical trials for FDA approval, is the primary investigator. His research includes testing new medicines for cutaneous conditions such as acne vulgaris, actinic keratosis, psoriasis, hyperhidrosis, and more. Our research staff has more than 25 years of combined experience and includes: Giovanna Paredes, Board Certified Nurse Practitioner and Sub Investigator; Anna Chockley, Director of Clinical Research; and John Defelice, Clinical Research Coordinator.

Current Clinical Trials

Current Clinical Trials

If your dermatologic concerns or conditions fit the descriptions below, you may be able eligible to participate in a clinical trial. Compensation is available to participants who qualify. Please check this page regularly if you are interested, as our trials and requirements change. To apply for or learn more about our clinical trials, please contact 305.652.8600, ext 322 or email us at studies@sullivandermatology.com.

Current Clinical Trials

  • Plaque Psoriasis

    We are looking for volunteers to participate in an eight-week research study of an investigational topical medication for psoriasis. Participants must be at least 18 years of age. Those who qualify for the study will receive at no cost:

    • Study-related medical evaluations by a dermatologist

    • Study-related medication

    • Reimbursement for time and travel, up to $200

  • Acne Vulgaris

    If you are between the ages of 12 and 40 and have facial acne (blackheads, whiteheads, and other blemishes) you may qualify for a research study testing a topical investigational medicine compared to a placebo. The study will require up to 4 office visits over a 12-week period, and insurance coverage is not required in order to participate. Those who qualify will receive:

    • Exams and study medication provided at no cost to you

    • Compensation up to $200 available to qualified participants

  • Athlete’s Foot

    If you are 12 years of age or older and have athlete’s foot (also known as Tinea Pedis) you may qualify for research study testing a topical investigational medication compared to placebo. The study takes place over a 6-week period, with up to three office visits. Those who qualify will receive:

    • Exams, Lab Tests, and Study medication provided at no cost to you

    • Compensation available to qualified participants

Dermatology Research

Dermatology Research

A graduate of Georgetown University, Vanderbilt University Medical School, and the University of Miami, Dr. Sullivan maintains strong ties to the academic and medical community through teaching, clinical research, and peer lecturing nationwide. His findings and advancements from his extensive medical research can be found in publications of the American Society of Dermatologic Surgery, The Wound Healing Society and the European Tissue Repair Society, and the Journal of Cutaneous Medicine and Surgery, among others.

Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses

Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping

Infliximab for hidradenitis suppurativa

Pemphigus and smoking

Surgical pearl: punch technique to improve granulation over exposed tendons in chronic wounds

A liquid adhesive bandage for the treatment of minor cuts and abrasions

The pig as a model for human wound healing

Colchicine in dermatology